"10.1371_journal.pone.0021643","plos one","2011-07-11T00:00:00Z","Xianlin Han; Steve Rozen; Stephen H Boyle; Caroline Hellegers; Hua Cheng; James R Burke; Kathleen A Welsh-Bohmer; P Murali Doraiswamy; Rima Kaddurah-Daouk","Sanford-Burnham Medical Research Institute, Orlando, Florida, United States of America; Department of Medicine, Duke-NUS Graduate Medical School, Singapore, Singapore; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, United States of America; Bryan Alzheimer Disease Research Center, Duke University Medical Center, Durham, North Carolina, United States of America; Duke Institute of Brain Sciences, Duke University Medical Center, Durham, North Carolina, United States of America","Conceived and designed the experiments: XH JB KWB PMD RKD. Performed the experiments: CH. Analyzed the data: SR. Contributed reagents/materials/analysis tools: XH. Wrote the paper: XH SR SB JB KWB PMD RKD. Participated in lipidomics profiling: HC.","RKD has patents in this field and has received funding from pharmaceutical companies for metabolomic studies. PMD has received research grants (through Duke) and consulting honoraria from several companies in this field. He owns stock in Sonexa. JRB has been advisor to GSK, Bristol Myers Squibb, and Accera. He is a consultant to Trans Tech and High Point Pharmaceuticals. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","07","Xianlin Han","XH",9,TRUE,5,1,1,7,TRUE,FALSE,FALSE,0,NA,FALSE
